<SEC-DOCUMENT>0000912282-25-001013.txt : 20251001
<SEC-HEADER>0000912282-25-001013.hdr.sgml : 20251001
<ACCEPTANCE-DATETIME>20251001173254
ACCESSION NUMBER:		0000912282-25-001013
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20251001
DATE AS OF CHANGE:		20251001

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Scinai Immunotherapeutics Ltd.
		CENTRAL INDEX KEY:			0001611747
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-89384
		FILM NUMBER:		251365738

	BUSINESS ADDRESS:	
		STREET 1:		JERUSALEM BIOPARK, 2ND FLOOR
		STREET 2:		HADASSAH EIN KEREM CAMPUS
		CITY:			JERUSALEM
		STATE:			L3
		ZIP:			00000
		BUSINESS PHONE:		972-8-9302529

	MAIL ADDRESS:	
		STREET 1:		JERUSALEM BIOPARK, 2ND FLOOR
		STREET 2:		HADASSAH EIN KEREM CAMPUS
		CITY:			JERUSALEM
		STATE:			L3
		ZIP:			00000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BiondVax Pharmaceuticals Ltd.
		DATE OF NAME CHANGE:	20140624

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			STONE DANIEL E.
		CENTRAL INDEX KEY:			0001948744
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A

	MAIL ADDRESS:	
		STREET 1:		1200 BRICKELL AVENUE, #1470
		CITY:			MIAMI
		STATE:			FL
		ZIP:			33131
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
<headerData>
<submissionType>SCHEDULE 13G/A</submissionType>
<previousAccessionNumber>0001567619-22-018298</previousAccessionNumber>
<filerInfo>
<filer>
<filerCredentials>
<cik>0001948744</cik>
<ccc>XXXXXXXX</ccc>
</filerCredentials>
</filer>
<liveTestFlag>LIVE</liveTestFlag>


</filerInfo>
</headerData>
<formData>
<coverPageHeader>
<amendmentNo>5</amendmentNo>
<securitiesClassTitle>American Depositary Shares, each representing 4,000 Ordinary Shares, no par value</securitiesClassTitle>
<eventDateRequiresFilingThisStatement>09/29/2025</eventDateRequiresFilingThisStatement>
<issuerInfo>
<issuerCik>0001611747</issuerCik>
<issuerName>Scinai Immunotherapeutics Ltd.</issuerName>
<issuerCusip>09073Q203</issuerCusip>
<issuerPrincipalExecutiveOfficeAddress>
<com:street1>Jerusalem BioPark, 2nd Floor</com:street1>
<com:street2>Hadassah Ein Kerem Campus</com:street2>
<com:city>Jerusalem</com:city>
<com:stateOrCountry>L3</com:stateOrCountry>
<com:zipCode>0000000</com:zipCode>
</issuerPrincipalExecutiveOfficeAddress>
</issuerInfo>
<designateRulesPursuantThisScheduleFiled>
<designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
</designateRulesPursuantThisScheduleFiled>
</coverPageHeader>
<coverPageHeaderReportingPersonDetails>

<reportingPersonName>Stone Daniel E.</reportingPersonName>
<citizenshipOrOrganization>X1</citizenshipOrOrganization>
<reportingPersonBeneficiallyOwnedNumberOfShares>
<soleVotingPower>346667</soleVotingPower>
<sharedVotingPower>0</sharedVotingPower>
<soleDispositivePower>346667</soleDispositivePower>
<sharedDispositivePower>0</sharedDispositivePower>
</reportingPersonBeneficiallyOwnedNumberOfShares>
<reportingPersonBeneficiallyOwnedAggregateNumberOfShares>346667</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
<aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
<classPercent>9.9</classPercent>
<typeOfReportingPerson>IN</typeOfReportingPerson>
</coverPageHeaderReportingPersonDetails>
<coverPageHeaderReportingPersonDetails>

<reportingPersonName>RK Stone Miami, LLC</reportingPersonName>
<citizenshipOrOrganization>FL</citizenshipOrOrganization>
<reportingPersonBeneficiallyOwnedNumberOfShares>
<soleVotingPower>282467</soleVotingPower>
<sharedVotingPower>0</sharedVotingPower>
<soleDispositivePower>282467</soleDispositivePower>
<sharedDispositivePower>0</sharedDispositivePower>
</reportingPersonBeneficiallyOwnedNumberOfShares>
<reportingPersonBeneficiallyOwnedAggregateNumberOfShares>282467</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
<aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
<classPercent>8.1</classPercent>
<typeOfReportingPerson>CO</typeOfReportingPerson>
<comments>Based on 12,750,715,584 ordinary shares outstanding as of September 17, 2025, as disclosed by the issuer on September 22, 2025.  Includes 64,200 American Depositary Shares (ADSs) held directly by the Reporting Person, 200,000 ADSs held by RK Stone Miami, LLC ("RK") and 82,467 ADSs issuable upon exercise of pre-funded warrants held by RK.  On September 22, 2025, RK exercised 200,000 warrants.  As of September 29, 2025, RK holds 200,000 ADSs and 283,426 ADS pre-funded warrants, which may not be exercised if such exercise would result in beneficial ownership by RK, together with its affiliates (which include the Reporting Person) and certain other persons, of greater than 9.99% of the ordinary shares.  As disclosed in the Schedule 13G amendment filed with the Securities and Exchange Commission on January 24, 2025, future issuances of ordinary shares or ADSs by the issuer to third parties are expected to cause additional amounts of pre-funded warrants to become exercisable within the foregoing limitation, without increasing the reporting person's beneficial ownership percentage.</comments>
</coverPageHeaderReportingPersonDetails>
<items>
<item1>
<issuerName>Scinai Immunotherapeutics Ltd.</issuerName>
<issuerPrincipalExecutiveOfficeAddress>Jerusalem BioPark, 2nd Floor, Hadassah Ein Kerem Campus, Jerusalem, Israel, 0000000</issuerPrincipalExecutiveOfficeAddress>
</item1>
<item2>
<filingPersonName>i) Daniel E. Stone&#13;
ii) RK Stone Miami, LLC</filingPersonName>
<principalBusinessOfficeOrResidenceAddress>i) 1200 Brickell Avenue, #1470, Miami, FL 33131&#13;
&#13;
ii)  1200 Brickell Avenue, #1470, Miami, FL 33131</principalBusinessOfficeOrResidenceAddress>
<citizenship>i) United States&#13;
ii) Florida</citizenship>
</item2>
<item3>
<notApplicableFlag>Y</notApplicableFlag>
</item3>
<item4>
<amountBeneficiallyOwned>i)  346,667&#13;
ii) 282,467</amountBeneficiallyOwned>
<classPercent>i) 9.9&#13;
ii) 8.1</classPercent>
<numberOfSharesPersonHas>
<solePowerOrDirectToVote>i) 346,667&#13;
ii) 282,467</solePowerOrDirectToVote>
<sharedPowerOrDirectToVote>0</sharedPowerOrDirectToVote>
<solePowerOrDirectToDispose>i) 346,667&#13;
ii) 282,467</solePowerOrDirectToDispose>
<sharedPowerOrDirectToDispose>0</sharedPowerOrDirectToDispose>
</numberOfSharesPersonHas>
</item4>
<item5>
<notApplicableFlag>Y</notApplicableFlag>
</item5>
<item6>
<notApplicableFlag>Y</notApplicableFlag>
</item6>
<item7>
<notApplicableFlag>Y</notApplicableFlag>
</item7>
<item8>
<notApplicableFlag>Y</notApplicableFlag>
</item8>
<item9>
<notApplicableFlag>Y</notApplicableFlag>
</item9>
<item10>
<notApplicableFlag>N</notApplicableFlag>
<certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.</certifications>
</item10>
</items>
<exhibitInfo>EXHIBIT 1.01 JOINT FILING AGREEMENT</exhibitInfo>
<signatureInformation>
<reportingPersonName>Stone Daniel E.</reportingPersonName>
<signatureDetails>
<signature>/s/ Daniel E. Stone</signature>
<title>Stone Daniel E.</title>
<date>10/01/2025</date>
</signatureDetails>
</signatureInformation>
<signatureInformation>
<reportingPersonName>RK Stone Miami, LLC</reportingPersonName>
<signatureDetails>
<signature>/s/ Daniel E. Stone</signature>
<title>Sole Member - RK Stone Miami, LLC</title>
<date>10/01/2025</date>
</signatureDetails>
</signatureInformation>
</formData>

</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.01
<SEQUENCE>2
<FILENAME>agm.htm
<DESCRIPTION>JOINT FILING AGREEMENT
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Dorsey & Whitney
         Document created using Broadridge PROfile 25.9.1.5330
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div><br>
  </div>
  <div><br>
  </div>
  <div style="text-align: center;">EXHIBIT 1.01 JOINT FILING AGREEMENT<br>
  </div>
  <div style="text-align: justify; margin-top: 12pt; margin-bottom: 12pt;">The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the
    undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be
    responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the
    others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.</div>
  <div style="margin-top: 12pt; margin-bottom: 12pt;">Dated: October 1, 2025</div>
  <div><br>
  </div>
  <table cellspacing="0" cellpadding="0" id="z37a40773fed5440499de95357951e6c6" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td style="width: 50%; vertical-align: top; border-bottom: 2px solid black;">
          <div>By: /s/ Daniel E. Stone</div>
        </td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td style="width: 50%; vertical-align: top;">
          <div>&#160;&#160;&#160;&#160;&#160;&#160;&#160;Daniel E. Stone</div>
        </td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td style="width: 50%; vertical-align: top;">
          <div style="font-weight: bold;">RK STONE MIAMI, LLC</div>
        </td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td style="width: 50%; vertical-align: top; border-bottom: 2px solid black;">
          <div>By: &#160;/s/ Daniel E. Stone</div>
        </td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td style="width: 50%; vertical-align: top;">
          <div>&#160;&#160;&#160;&#160;&#160;&#160;&#160;Name: Daniel E. Stone</div>
          <div>&#160;&#160;&#160;&#160;&#160;&#160;&#160;Title: Manager</div>
        </td>
      </tr>

  </table>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
